Modeling of Chronic Lung Inflammation in Rats by Repeated Intratracheal Administration of LPS

V A Palikov1, Yu A Palikova1, P A Rudenko1

  • 1Branch of M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Pushchino, Moscow region, Russia.

Insights

This study developed a rat model for chronic lung inflammation using lipopolysaccharide (LPS). LPS exposure caused lung damage and altered blood cell counts, including monocytopenia and reduced hemoglobin.

Area of Science:

  • Pulmonary Medicine
  • Toxicology
  • Immunology

Background:

  • Chronic lung inflammation models are crucial for understanding respiratory diseases.
  • Lipopolysaccharide (LPS) is a potent inducer of inflammation.
  • Developing reliable animal models is essential for preclinical research.

Purpose of the Study:

  • To establish and characterize a rat model of chronic lung inflammation.
  • To investigate the hematological and pathological changes induced by repeated LPS administration.

Main Methods:

  • SPF Sprague-Dawley rats were used.
  • Chronic lung inflammation was induced via repeated intratracheal administration of LPS (0.4 mg/kg).
  • Hematological parameters and lung/spleen/trachea tissues were analyzed on day 22.

Main Results:

  • LPS administration induced lung inflammation with atelectasis, emphysema, and cellular infiltration (mononuclear and neutrophilic).
  • Rats exposed to LPS exhibited relative monocytopenia, reduced erythrocyte hemoglobin concentration, and decreased mean platelet volume.
  • Spleen lymphoid follicles showed germinal centers, and tracheal mucosa displayed mononuclear infiltration.

Conclusions:

  • Repeated intratracheal LPS administration effectively models chronic lung inflammation in rats.
  • This model elicits significant pulmonary pathology and systemic hematological alterations.
  • The model provides a valuable tool for studying inflammatory lung diseases and potential therapeutic interventions.

Related Concept Videos